Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Amortizatization of Intangibles: 2020-2025

Historic Amortizatization of Intangibles for Silence Therapeutics (SLN) over the last 5 years, with Sep 2025 value amounting to $75,000.

  • Silence Therapeutics' Amortizatization of Intangibles rose 15.38% to $75,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $271,000, marking a year-over-year increase of 32.73%. This contributed to the annual value of $257,000 for FY2024, which is 1.98% up from last year.
  • Silence Therapeutics' Amortizatization of Intangibles amounted to $75,000 in Q3 2025, which was up 11.94% from $67,000 recorded in Q2 2025.
  • Silence Therapeutics' Amortizatization of Intangibles' 5-year high stood at $75,000 during Q3 2025, with a 5-year trough of $1,179 in Q3 2022.
  • In the last 3 years, Silence Therapeutics' Amortizatization of Intangibles had a median value of $64,000 in 2024 and averaged $46,229.
  • As far as peak fluctuations go, Silence Therapeutics' Amortizatization of Intangibles plummeted by 80.54% in 2022, and later surged by 2,457.21% in 2024.
  • Silence Therapeutics' Amortizatization of Intangibles (Quarterly) stood at $2,696 in 2021, then tumbled by 78.63% to $1,179 in 2022, then surged by 867.31% to $11,170 in 2023, then surged by 472.94% to $64,000 in 2024, then rose by 15.38% to $75,000 in 2025.
  • Its Amortizatization of Intangibles stands at $75,000 for Q3 2025, versus $67,000 for Q2 2025 and $65,000 for Q1 2025.